🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to determine if TAR-200, an investigational dr...
Status
Completed
Location
University of Southern California Norris Comprehensive Cancer Center
Start Date
2016-05-31
Trial ID
NCT02722538
Treatments Being Tested
By doing this study the investigators hope to learn if educational videos f...
Status
Completed
Location
University of Kansas Medical Center
Start Date
2018-06-28
Trial ID
NCT03801954
Treatments Being Tested
Objectives: To evaluate the non-inferiority of disitamab vedotin plus gemci...
Status
Recruiting
Location
The First Affiliated Hospital of Anhui Medical University
Start Date
2026-07-01
Trial ID
NCT07693959
Treatments Being Tested
The purpose of the study is to see if treatment with nivolumab plus bempega...
Status
Completed
Location
Local Institution - 0080
Start Date
2020-02-05
Trial ID
NCT04209114
Treatments Being Tested
Erdafitinib (ERDA) alone or in combination with cetrelimab (CET) as neoadju...
Status
Recruiting
Location
CLCC Jean Perrin
Start Date
2023-03-07
Trial ID
NCT06511648
Treatments Being Tested
This prospective randomized controlled trial (RCT) is designed to provide h...
Status
Active Not Recruiting
Location
Riccardo Mastroianni
Start Date
2026-08-13
Trial ID
NCT05776758
Treatments Being Tested
The purpose of this study is to assess participant's overall well-being and...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-09-30
Trial ID
NCT07735793
There is no consensus on the need for lymph node dissection in radical cyst...
Status
Recruiting
Location
The first affiliated hospital of Nanjing Medical University
Start Date
2021-07-01
Trial ID
NCT05123625
Treatments Being Tested
Bladder cancer is a common malignancy in the urinary system, ranking 11th i...
Status
Recruiting
Location
The first affiliated hospital of Nanjing Medical University
Start Date
2024-12-01
Trial ID
NCT06735287
Treatments Being Tested